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A B S T R A C T
Purpose: Bilateral electrical stimulation of anterior nuclei of thalamus (ANT) has shown promising
effects on epileptic seizures. However, bilateral implantation increases the risk of surgical complications
and side effects. This study was undertaken to access the effectiveness of a stimulation paradigm
involving high frequency and low intensity currents to stimulate the left ANT in rats.
Methods: Male Sprague-Dawley rats were implanted with electroencephalogram (EEG) electrodes, and
an additional concentric bipolar stimulation electrode into either the left or right ANT. The stimulus was
a train of pulses (90 ms duration each) delivered with a frequency of 200 Hz and a current intensity of
50 mA. Thalamic stimuli were started 1 h before the ﬁrst intraperitoneal pilocarpine injection (i.p.,
300 mg/kg), and were applied for 5 h.
Results: EEG documented seizure activity and status epilepticus (SE) developed in 87.5% of rats treated
with no ANT stimulation after a single dose of pilocarpine. Left ANT stimulation signiﬁcantly increased
the tolerance threshold for pilocarpine-induced EEG seizure activity; 20% of rats developed their EEG
documented seizure activity after receiving the ﬁrst dose, whereas 50%, 10% and 20% of rats did not
develop seizure activity until they had received the 2nd, 3rd and 4th pilocarpine injection at 1-h
intervals. Moreover, left thalamic stimulation reduced the occurrences of both EEG documented seizure
activity and SE induced by single-dose pilocarpine to 25%. However, our result demonstrated that little
effect on the occurrence rate of seizures and SE was found when rats received right ANT stimulation.
Conclusions: These results suggest that continuously 5-h left ANT stimulation with high frequency and
low intensity currents, beginning from 1 h before the pilocarpine administration, may successfully
reduce the occurrence rate of EEG documented seizure activity and SE development in rats.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is one of the most common and devastating
neurological disorders. About seventy percent of patients with
epilepsy can be well-controlled with currently available anti-
epileptic drugs (AEDs), but seizures still persist in 30% of epilepsy
patients who do not respond to any of two to three ﬁrst-line AEDs
despite administration of the carefully optimized drug treatment.1* Corresponding author at: Department of Veterinary Medicine, School of
Veterinary Medicine, National Taiwan University, No. 1, Sec. 4., Roosevelt Road,
Taipei 106, Taiwan, ROC. Tel.: +886 2 3366 3883; fax: +886 2 2366 1475.
E-mail address: fchang@ntu.edu.tw (F.-C. Chang).
1 Shuo-Bin Jou and I-Feng Kao contributed equally to this work and should be
considered co-ﬁrst authors.
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.12.015Many patients with epilepsy are inadequately controlled by the
AEDs and also are not eligible for resective surgery. Alternative
therapies, such as vagus nerve stimulation2,3 and deep brain
stimulation (DBS), have been considered for treating refractory
epilepsy.
DBS has been used to treat various psychiatric (e.g., depression
and obsessive-compulsive disorder)4–7 and neurological disorders,
such as Parkinson’s disease (PD)8 and epilepsy.9–12 Stimulation of
the subthalamic nucleus (STN) improves the cardinal features of
PD, and the pedunculopontine (PPN) nucleus has recently emerged
as a possible target of DBS for gait disorders in PD.8 The targeted
structures of DBS used for depression include the subthalamic
nucleus, internal globus pallidus, ventral internal capsule/ventral
striatum, the subgenual cingulated region, and the nucleus
accumbens.6 Amygdala and nucleus accumbens have beenvier Ltd. All rights reserved.
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(PTSD)5 and refractory obsessive-compulsive disorder,4 respec-
tively. Bilateral electrical stimulation of the anterior nuclei of the
thalamus (ANT) is promising in reducing epilepsy in animal
experiments11,12 and human studies.9,10 The efﬁciency of the ANT
stimulation in treating refractory epilepsy depends on the
stimulation paradigm. Low frequency stimulation synchronizes
electroencephalic activity in cortex13,14 and is proconvulsant;15
whereas high frequency stimulation desynchronizes intrinsic
cortical activity16 and raises seizure threshold.15 Furthermore,
unilateral DBS of the ANT has not been shown to reduce the
propensity or latency for developing seizures and status epilepti-
cus (SE).11 However, bilateral implantation of electrodes into the
ANT increases the complexity of surgery, the risk of surgery
complication and adverse effects (e.g., intracranial and intracere-
bral hemorrhage, infection, misplacement of the DBS leads, or
suboptimal placement of the leads).17 We herein reported a
stimulation paradigm by employing the relatively high-frequency
(200 Hz) and low-intensity currents (50 mA) to unilaterally
stimulate the left ANT, which successfully reduced the occurrence
rate of pilocarpine-induced seizures and SE in rats.
2. Methods
2.1. Substances
Stock solutions of pilocarpine and methylscopolamine bromide
(Sigma–Aldrich, St. Louis, MO, USA) were dissolved in pyrogen-free
solution (PFS). These stock solutions were stored at 20 8C until
administration. The dose of pilocarpine used in these experiments
was 300 mg/kg with intraperitoneal (i.p.) injection. Methylscopo-
lamine bromide (1 mg/kg, ip), an anti-cholinergic that does not
cross the blood–brain barrier, was administered to reduce the
peripheral cholinergic effects without affecting the central nervous
system (CNS). Our personal observation demonstrated that rats
would not survive after SE if the injection dose of pilocarpine is
over 300 mg/kg. Therefore, we selected the dose of 300 mg/kg
pilocarpine to provoke seizures.
2.2. Animals
Male Sprague-Dawley rats (250–300 g; National Laboratory
Animal Breeding and Research Center, Taiwan) were used in these
experiments. These animals were anesthetized (Zoletil1 (Carros,
France); 50 mg/kg), and injected with analgesic (morphine) and
antibiotic (penicillin G benzathine). All rats were surgically
implanted with three electroencephalogram (EEG) screw electro-
des (on the right frontal and parietal lobes and the left occipital
lobe) as previously described.18 An additional concentric bipolar
electrode (O.D. 0.125 mm, FHC, Bowdoinham, ME, USA) was
implanted directly into the left ANT (AP, 2.0 mm from bregma;
ML, 1.5 mm; DV, 5.5 mm)19 in rats of groups 2–5 (see later in the
experimental protocol). Insulated leads from EEG electrodes were
routed to a Teﬂon pedestal (Plastics One, Roanoke, VA, USA). The
Teﬂon pedestal was then cemented to the skull with dental acrylic
(Tempron, GC Co., Tokyo, Japan). The incision was treated topically
with polysporin (polymyxin B sulfate–bacitracin zinc) and the
animals were allowed to recover for seven days prior to the
initiation of experiments. The rats were housed separately in
individual recording cages in an isolated room, in which the
temperature was maintained at 23  1 8C and the light:dark rhythm
was controlled in a 12:12 h cycle (40 W  4 tubes illumination). Food
and water were available ad libitum. On the second postsurgical day,
rats were connected to the recording apparatus (see later) via a
ﬂexible tether. Animals were habituated by daily handling timed to
coincide with scheduled experimental administrations. We made ourbest effort to minimize animal suffering and to reduce the number of
animals used in current study. All procedures performed in this study
were approved by the National Taiwan University Animal Care and
Use Committee.
2.3. Recording apparatus and ANT stimulation
Signals from the EEG electrodes were fed into an ampliﬁer
(Colbourn Instruments, Lehigh Valley, PA; model V75-01). The EEG
was ampliﬁed (factor of 5000) and analog bandpass was ﬁltered
between 0.1 and 40 Hz (frequency response: 3 dB; ﬁlter frequency
roll off: 12 dB/octave). These conditioned EEG signals were subjected to
analog-to-digital conversion with 16-bit precision at a sampling rate of
128 Hz (NI PCI-6033E; National Instruments, Austin, TX). The digitized
EEG waveforms were stored as binary computer ﬁles pending
subsequent analyses. Postacquisition determination of the onset of
the ﬁrst EEG seizure occurrence and the latency to SE was done by the
visual scoring using AxoScope 10 Software (Molecular Devices,
Sunnyvale, CA, USA). We deﬁned EEG documented seizures as the
visualization of epileptiform spikes with amplitudes of greater than
1 mV appearing in discharges lasting for at least 30 s. SE was deﬁned as
seizure activity associated with continuous epileptiform discharges
followed by the periodic epileptiform discharges of at least 5 min
duration.20 EEGs were analyzed with the open-source Chronux
algorithms (http://chronux.org/) run by the Matlab Signal Processing
Toolkit for the fast Fourier transform (FFT) and multi-taper time-
frequency spectrum.
Thalamic stimulation was started 1 h before pilocarpine i.p.
injection and lasted for 5 h. A stimulator-isolator unit (A360 Stimulus
Isolator, World Precision Instruments, Sarasota, FL, USA) triggered by
a main stimulator (Accupulser A310, World Precision Instruments)
was used to deliver the ANT stimulation current at a frequency of
200 Hz, pulse width 90 ms, interval 4.1 ms, and intensity 50 mA. The
stimulation artifact was not observed during the stimulation time
period because of the low sampling rate with which the EEG was
acquired. However, we simultaneously determined the stimulation
outputs by oscilloscope when the animals received ANT stimuli. The
parameters of ATN stimulation with high-frequency and low-
intensity currents would deliver the lowest possible total electrical
energy delivered (TEED) than that of low-frequency and high-
intensity currents.21 The TEED is calculated as: TEED1 s = (volta-
ge2 frequency  pulse width/impedance)  1 s.21 The optimized
DBS setting should generate maximal clinical beneﬁt at the lowest
possible TEED, which results in fewer stimulation-related complica-
tions. Furthermore, the ANT stimulation did not alter the quality of
EEG signals as mentioned in the following result section.
2.4. Experimental procedures
A total of 50 Sprague-Dawley rats were used and divided into six
groups. Control rats in group-1 (n = 8) received a single dose of
pilocarpine administration at the second hour of the dark period.
EEGs were recorded before and after pilocarpine injection. Rats in
group-2 received a similar protocol as those in group-1, except that
rats were implanted with a left ANT electrode but electrical
stimulation was not delivered. In group-3 (n = 10), a 1-h baseline
EEG was recorded at the beginning of the dark period. The continuous
5-h left ANT stimulation and EEG recording were simultaneously
performed from the 2nd-hour of the dark period. The ﬁrst i.p.
administration of pilocarpine was given 1 h after the initiation of ANT
stimulation. The second dose of pilocarpine was given 1 h later if the
EEG epileptiform did not occur after the ﬁrst pilocarpine injection.
The third and fourth injections of pilocarpine were given at 1-h
interval if the previous dose of pilocarpine did not cause EEG
epilepsy. Rats in group-4 (n = 8) received the similar protocol as
those in group-3, except that pilocarpine was administered once at
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(n = 6) had the similar protocol as those of group-4, except that rats
received right ANT stimulation. Rats in group-4 and group-5
received the same DBS procedure, which was performed using
the same equipment and by same investigators. The only difference
was that the stimulation target in group-4 was the left ANT and the
target in group-5 was the right ANT. Rats in group-6 (n = 8) received
the similar protocol as those in group 3, except that pilocarpine was
administered once at 30 min after the beginning of the left ANT
stimulation. Rats from these six groups were sacriﬁced two days
after the end of ANT stimuli, if animals survived; and the dissected
brain tissue blocks were perfused with 4% paraformaldehyde for
ﬁxation. Then, 40 mm thick brain slices containing the ANT region
were sliced coronally by cryotome at the same brain level and were
used to verify the ANT lesion caused by stimulation electrode or
electrical stimulation.
2.5. Statistical analyses
All values acquired from the EEG recordings were presented as
the mean  SEM for the indicated sample sizes. The nonparametric
Mann–Whitney and Chi Square (x2) tests were used. An a level <0.05
was taken as indicating a statistically signiﬁcant difference.Fig. 1. EEG recordings before and after the pilocarpine administration. Arrow indicates th
the pilocarpine administration, panel B depicts the ﬁrst EEG seizure, and panels C & D3. Results
3.1. Effects of pilocarpine-induced EEG epilepsy and behavior changes
Administration of pilocarpine induced severe behavioral signs
of cholinergic effects, including piloerection, salivation, red eyes,
shivering and facial automatisms, within 5 min in the group-1 rats.
The severity of cholinergic behavioral signs gradually increased
until the development of EEG seizures. The latency to develop the
ﬁrst EEG seizure was 12.3  2.3 min obtained from seven out of eight
rats (87.5%), which received a single-dose pilocarpine administration
in group-1 (Fig. 1, Table 1). Furthermore, seven out of eight (87.5%)
rats developed SE with a latency of 22.3  5.0 min after the single-
dose pilocarpine injection (Fig. 1, Table 1). This result indicated that
300 mg/kg pilocarpine is a dosage which reliably leads to the
development of EEG documented seizures and SE in our model. None
of the rats which developed SE survived.
3.2. Effects of left or right ANT stimulation given 1-h before
pilocarpine administration
Left ANT stimulation did not alter EEGs when compared to the
EEGs acquired from the undisturbed baseline, whenever rats wereat injection of pilocarpine. Panel A demonstrates the baseline EEGs obtained before
 indicate the EEG with SE. Panels a–d are EEGs extracted from panels A–D.
Table 1
Effects of right or left ANT DBS on the occurrence rates of ﬁrst EEG seizure and SE, the survival rate, and the latencies to develop ﬁrst EEG seizure and SE.
Group Total
sample size
Number of
rats develop
EEG seizure
Number
of rats
develop SE
Number of
rats survived
Latency to develop
ﬁrst EEG seizure
Latency to develop SE
Group 1 (pilocarpine control) 8 7 7 1 12.3  2.3 min 22.3  5.0 min
Group 2 (Sham control: Left
ANT electrode implanted)
10 8 5 8 25.1  7.9 min 41.3  11.0 min
Group 3 (left ANT DBS with
repeated pilocarpine injections)
10 2 2 8 Not determinedb Not determinedb
Group 4 (left ANT DBS)a 8 2 2 8 23.4  10.1 min 37.7  14.4 min
Group 5 (right ANT DBS) 6 6 6 0 24.7  7.7 min 47.8  16.3 min
Group 6 (left ANT DBS)a 8 5 5 3 11.9  1.8 min 17.4  2.5 min
a Rats in group-4 received left ANT DBS 60 min prior to pilocarpine administration, whereas rats in group-5 received left ANT DBS 30 min before pilocarpine injection.
b Rats in group-3 received repeated pilocarpine administrations (see Section 2.4), therefore the latencies for developing ﬁrst EEG seizure and SE were not determined.
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(Fig. 2C). Further analyzing the EEG spectra during wakefulness
and SWS indicated that no signiﬁcant alteration was induced by
the left ANT stimulation (Fig. 2B and D), suggesting that the present
paradigm of thalamic stimulation did not alter spontaneous EEGs.
The propensity for pilocarpine to induce EEG seizure and develop
SE was reduced to 25% (two out of eight rats) when rats received
left ANT stimulation 1 h before pilocarpine injection in the group-4
(Fig. 3, Table 1). The upper panel of Fig. 3 demonstrated an example
of EEGs in which no epileptiform activity was observed when rats
received the left ANT DBS. However, two out of eight rats did
exhibit epileptiform EEGs despite treatment with the left ANT DBS
as shown in the second panel. There was a statistically signiﬁcant
association between the left ANT DBS and the efﬁciency for
reducing the rate of EEG seizure in rats (x2 = 12.30, p < 0.001,Fig. 2. Effects of left ANT DBS on baseline EEGs. A: Upper panel demonstrates the baseline
depicts the spectral analysis from the baseline waking EEG; lower panel indicates the spec
blue: low intensity. C: Upper panel demonstrates the baseline SWS EEG and lower panel i
from baseline SWS EEG; lower panel indicates the spectral analysis obtained from t
interpretation of the references to color in this ﬁgure legend, the reader is referred to when comparing to the control group). Furthermore, the associa-
tion between the left ANT DBS and the efﬁciency for reducing the
rate of SE in rats also demonstrated statistical signiﬁcance
(x2 = 12.30, p < 0.001, when comparing to the control group).
The onset of the ﬁrst EEG seizure (23.4  10.1 min) and the latency
to develop SE (37.7  14.4 min) were also prolonged in the two rats
which received the left thalamic stimulation but still developed
seizure and SE, although this observation failed to reach statistical
signiﬁcance when compared to the pilocarpine-treated control rats
without receiving left ANT stimulation (p = 0.182 & 0.355, respec-
tively; Mann–Whitney test). The reason for not achieving statistical
signiﬁcance between groups may be due to the small group sizes.
Comparing to the effect of left ANT stimulation, all of 6 rats in the
group-5, which received the right ANT DBS, developed pilocarpine-
induced EEG seizures and SE (Table 1). However, the onset of the ﬁrst waking EEG and lower panel is the EEG acquired during left ANT DBS. B: Upper panel
tral analysis obtained from the waking EEG during left ANT DBS. Red: high intensity;
s the EEG acquired during left ANT DBS. D: Upper panel depicts the spectral analysis
he SWS EEG during left ANT DBS. Red: high intensity; blue: low intensity. (For
the web version of the article.)
Fig. 3. Effects of left ANT DBS on pilocarpine-induced epileptogenesis. Upper panel is an example demonstrated that the left ANT DBS successfully suppressed pilocarpine-
induced EEG seizure. Lower panel is a failure example for left ANT DBS to suppress epileptogenesis. Panels A–J are EEGs extracted from these two EEG traces. H: the EEG
seizure, I & J: SE EEGs. Arrows indicate the administration of pilocarpine.
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24.7  7.7 min (p = 0.130 when compared to the values obtained
from group-1) and 47.8  16.3 min (p = 0.114 when compared to
the values acquired from group-1), respectively, after receiving
right ANT stimuli, although these alterations did not reach
statistical signiﬁcance when compared to that of control group-1
(Table 1). Rats in group-2, which were implanted with a left ANT
electrode but which did not receive any electrical stimulation, did
not show a signiﬁcant reduction of the occurrence rate of seizures.
The latencies to ﬁrst EEG seizure and SE were prolonged, but did
not reach statistical signiﬁcance (Table 1). Furthermore, left ANT
stimulation signiﬁcantly increased the tolerance threshold for
pilocarpine to induce the occurrence of EEG seizures in the group-3
rats; 20% (2/10) of rats developed their ﬁrst EEG seizure after
receiving the ﬁrst dose, whereas 50% (5/10), 10% (1/10) and 20% (2/
10) of rats did not induce the ﬁrst EEG seizure until receiving the
2nd, 3rd and 4th pilocarpine injection, respectively. Fig. 4
demonstrates that the ﬁrst epileptiform EEG appeared after thethird pilocarpine administration, and the SE occurred after the
fourth injection.
3.3. Effects of left ANT stimulation given 30-min before pilocarpine
administration
The propensity for one-dose of pilocarpine to induce EEG seizure
and develop SE was 62.5% (ﬁve out of eight rats) when rats in the
group-6 received left ANT stimulation 30 min before the pilocarpine
injection. There was no statistically signiﬁcant association between
the left ANT DBS (starting 30-min before pilocarpine administration)
and the efﬁciency for reducing the occurrence rate of EEG seizure and
SE in rats. The onset of the ﬁrst EEG seizure and the latency to develop
SE were 11.9  1.8 min (p = 0.935 when compared to the values
obtained from group-1; Mann–Whitney test) and 17.4  2.5 min
(p = 0.808 when compared to the values obtained from group-1;
Mann–Whitney test), respectively, which did not differ from those
values obtained from rats received only pilocarpine administration.
Fig. 4. Effects of left ANT DBS on the tolerance threshold for pilocarpine to induce the occurrence of EEG seizures. A: EEGs recorded before pilocarpine administration. B: EEGs
acquired after the 1st pilocarpine injection. C: EEGs recorded after the 2nd administration. D & E: normal EEGs and epileptiform EEGs obtained after the 3rd injection. F & G: SE
EEGs acquired after the 4th pilocarpine injection. Arrows indicate the administration of pilocarpine.
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Our results demonstrated that the left ANT electrical stimula-
tion did not cause obvious lesion in the ANT brain regions (Fig. 5).
Fig. 5A indicated the ANT slice obtained from one representative
rat in the control group-1, and Fig. 5B depicted the ANT region
acquired from a rat with the 5-h ANT electrical stimulation
(magniﬁcation: 100) in the group-4. There was no lesion
observed in a 400-magniﬁed slice obtained after the ANT DBS
stimulation when compared with the slice acquired from the
control rat (Fig. 5C and D). Nonetheless, the ANT stimulating
electrode may have caused a minimal lesion, but it would not be
realistic to claim that the electrode did not cause lesion at all. The
microscopic lesion or the changes in the cellular and molecular
levels by the electrode implantation or stimulation need to be
further studied.
4. Discussion
4.1. Efﬁcacy of DBS for epilepsy in humans and animal studies
Our results demonstrated that unilateral left ANT DBS with
high-frequency and low-intensity currents successfully reduces
the development of seizures and SE in an animal model. In the
treatment of neurological diseases, DBS was initially used for
movement disorders (e.g., Parkinson’s disease)22 and for chronicpain.23 Recently DBS has become a promising therapy for patients
with refractory epilepsy who do not respond adequately to AEDs or
are not eligible for resective surgery. The ﬁrst trial to assess the
effect of DBS in epilepsy was carried out by Cooper et al. in 1970s,
in which the seizure frequency was reduced by subdural
stimulation of the cerebellum.24–26 Several targets of deep brain
structures, including the anterior thalamus,27 the centromedian
thalamic nucleus,28 the caudate nucleus,29 the posterior hypothal-
amus,30 the hippocampus,31 and the STN,32 have been stimulated
to try and suppress seizures. The ANT receives afferents from the
mammillary bodies and subiculum via the mammillothalamic
tract and the fornix, respectively. The efferent of ANT projects to
the prefrontal cortex and cingulate gyrus,33,34 which subsequently
projects to the parahippocampal gyrus and entorhinal cortex.33
The ANT also has direct projections to the retrohippocampal
regions, which links the hippocampal formation with the
neocortical association areas.35,36 The mesial temporal lobe plays
a primary role in the genesis of temporal lobe epilepsy (TLE). The
mesial temporal lobe is composed of the hippocampus, the
amygdala and the parahippocampal regions (e.g., entorhinal
cortex, perihinal cortex and posterior parahippocampal cortex).37
Therefore, the ANT is an important relay nucleus of the Papez
circuit which exhibits an ability to manipulate (aggravate or
suppress) the epileptogenesis of TLE.
The rationale for DBS suppressing epileptogenesis is based upon
animal experiments and clinical studies in humans. In animal
Fig. 5. Effects of electrode implantation and electrical stimulation on the ANT lesion. A: The slice (100) of ANT obtained from one representative rat in control group-1. B: The
slice (100) of ANT obtained from a rat treated with the left ANT DBS in the group-4. Areas marked indicate the left ANT region. Arrow depicted the track of stimulation
electrode. C: The slice (400) of ANT obtained from one representative rat in control group-1. D: The slice (400) of ANT obtained from a rat treated with the left ANT DBS in
the group-4.
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stimulation of thalamus with lower frequency synchronizes
rhythmically recurrent cortical potentials in several cortical
regions.13 In contrast, bipolar electrical stimulation of medial
thalamic nuclei with high frequencies (200 Hz) desynchronizes
intrinsic cortical activities in the motor and somesthetic areas in
rabbits, which is similar to the result of reticular arousal
activation.16 Furthermore, the slow rhythms and the spindle
activity simultaneously disappeared after receiving the high-
frequency thalamic stimulation.16 The effects of thalamic
stimulation have been further conﬁrmed in human studies.
Electrical stimulation of centromedian thalamic nucleus with a
current of low frequency (6 Hz) and high intensity (320–800 mA)
elicits incremental, desynchronizing and spike-wave electrocor-
tical responses with a bilateral regional scalp distribution.38
Stimulation of centromedian thalamic nucleus with high fre-
quency (60 Hz) and high intensity (320–800 mA) currentsdesynchronizes EEG and exhibits a slow negative shift of the
EEG baseline.38
4.2. Complications/limitations of high-intensity bilateral DBS
stimulation
Bilateral thalamic stimulation with a high-intensity current
(320–800 mA) in animals11 and in humans38 is necessary for
ensuring the efﬁcacy of anti-epileptogenesis. Some reports even
used a high-voltage (5 V) stimulation of ANT to achieve the
successful anti-epileptogenetic effect.10 However, the bilateral
implantation of stimulation electrodes into the ANT may increase
the risk of surgery complication and the chance of suffering from
adverse effects (e.g., intracranial and intracerebral hemorrhage,
infection, misplacement of the DBS leads, or suboptimal placement
of the leads).17 Furthermore, ANT DBS with high-intensity or high-
voltage currents may impair the cognitive function and memory,
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for memory. An animal study demonstrated that the ANT
stimulation at relatively high current (500 mA) disrupts the
acquisition of contextual fear conditioning and impairs perfor-
mance on a spatial alternating task in rats.39 Therefore, ﬁnding an
effective and feasible stimulation paradigm of the unilateral ANT
DBS stimulation is necessary for employing this technique in the
treatment of refractory epilepsy. We herein hypothesized that
application of a unilateral ANT DBS with high-frequency (200 Hz)
and low-intensity (50 mA) currents at 1 h or 30 min before the
pilocarpine administration could suppress pilocarpine-induced
epileptogenesis.
4.3. Previous attempts to treat seizures with unilateral ANT
stimulation
Several studies indicate that bilateral high-frequency stimula-
tion of ANT and lesion of ANT are protective against the occurrence
of seizure and SE.11,15 Bilateral ANT stimulation at a frequency of
100 Hz, pulse width 100 ms, and intensity 800 mA, started 5 min
prior to pilocarpine administration, prolongs the latency to
develop SE; however, unilateral ANT stimulation exhibits no effect
on the pilocarpine-developed SE.11 Another study has also
demonstrated that high frequency stimulation (150 Hz, 450–
800 mA) of bilateral ANTs, performed immediately before or after
amygdala kindling-induced seizure, reduces the incidence of
seizure occurrence.40 However, unilateral high-frequency stimu-
lation of ANT fails to inhibit kindling-induced seizures.40 These
observations suggest the efﬁcacy of bilateral ANT DBS, rather than
that of unilateral ANT DBS, on the inhibition of seizure and SE.
Nevertheless, two recent studies revealed the effect of unilateral
ANT DBS on reducing seizure and SE in animal models. Takebayashi
et al. (2007) have demonstrated that unilateral ANT stimulation at
a frequency of 130 Hz, pulse width 100 ms, and intensity 140–
500 mA, delivered after injection of kainic acid into the left
sensorimotor cortex, suppresses focal cortical seizure.41 Further-
more, unilateral ANT DBS at a frequency of 200 Hz, pulse width
100 ms, and intensity 450–800 mA, given before kindling stimula-
tion and lasted for 15 days, decreases the incidence of generalized
seizures and after discharge duration induced by amygdala
kindling stimuli.42
Our current results indicate that high-frequency unilateral ANT
DBS did not disturb the baseline EEGs acquired from states of
wakefulness and SWS as shown in Fig. 2. There was no signiﬁcant
artifact observed in the waking and sleep EEGs during the
unilateral ANT DBS. Furthermore, analysis of EEG spectra before
and after unilateral ANT DBS depicted that no alteration was found,
suggesting the high-frequency unilateral ANT DBS has limited
adverse effect on normal baseline EEGs. Pilocarpine administration
induced epileptiform EEG seizure in 87.5% of rats, and 87.5% of rats
developed SE after administration. None of the rats which
developed SE survived. This result indicated that 300 mg/kg
pilocarpine is a feasible dosage to develop EEG seizure and SE in
our current study. Both the occurrence rates of pilocarpine-
induced epileptogenesis and SE were reduced to 25% when left ANT
DBS was employed 1 h before the pilocarpine administration and
lasted for 5 h. The onset of the ﬁrst EEG seizure and the latency to
develop SE were prolonged in the two out of eight rats which
received the left thalamic stimulation but still developed seizure
and SE. However, our result demonstrated that little effect on the
occurrence rate of seizure and SE was found when rats received the
right ANT stimulation. There is no biologically plausible explana-
tion of why the right ANT DBS exhibits no effect of seizure
suppression. Although the right ANT DBS was not effective in
suppression of seizure occurrence, it prolonged the latency for the
development of seizure and SE. With such small sample sizes, n = 6,a high degree of variability is to be expected and signiﬁcant
differences can occur by chance. It is unclear if a larger number of
animals could have led to signiﬁcant difference. Furthermore, the
left ANT DBS became less efﬁcient in suppressing the occurrence
rate of EEG seizure and SE, if the stimulation was starting at 30 min
prior to pilocarpine administration. This observation suggests that
giving the current paradigm of left ANT DBS to reduce the
occurrence rate of seizures with a certain period of time (e.g.,
60 min) prior to the pilocarpine administration is required.
Furthermore, the 5-h left ANT DBS starting at 1 h before the 1st
pilocarpine injection increased the tolerance threshold for
pilocarpine to induce the occurrence of EEG seizures. These results
suggest that the pilocarpine-induced epileptogenesis can be
successfully antagonized by unilateral left ANT DBS with high-
frequency (200 Hz) and low-intensity (50 mA) currents. This
efﬁcacy of unilateral left ANT DBS on seizure suppression is
contradictory to the other studies.11,40 We proposed the difference
might be due to the timing for administering unilateral ANT DBS. In
the previous studies with no efﬁcacy of unilateral ANT DBS on
seizure suppression, the timing for administering unilateral ANT
DBS is either 5 min prior to the pilocarpine injection11 or
immediately before/after amygdala kindling stimuli.40 Our current
results elucidated that left thalamic stimuli delivering 30 min prior
to the pilocarpine administration lost its ability to reduce seizures
and SE, suggesting that the left ANT DBS should be employed at
least 30 min prior to the seizure onset to ensure its efﬁcacy. One
study demonstrates that unilateral ANT DBS delivered 15 days
before amygdala kindling stimulation successfully decreases the
incidence of seizure and after discharge duration,42 which is
consistent with our current ﬁndings. Furthermore, the optimized
DBS setting should generate maximal clinical beneﬁt at the lowest
possible TEED, which results in fewer stimulation-related com-
plications. The stimulation intensity and TEED we used in this
study to reduce the rate of seizure and SE is much lower than
others,41,42 suggesting that our parameters of left ANT DBS for
seizure reduction is feasible and could minimize the stimulation-
related complications.
4.4. Limitations
Although this DBS paradigm did not affect the baseline EEG
activities and spectra during stimulation, the alteration of synaptic
plasticity after the long-term and high-frequency DBS may occur
and the effect of changing in the synaptic strength needs to be
considered in future study. In addition to the possible effect on
synaptic strength, the ANT lesion caused by DBS may also inﬂuence
the outcome of ANT DBS on anti-epileptogenesis. One study
reported that neither pilocarpine-induced generalized seizures nor
SE was developed after the bilateral thalamotomy, but both
seizures and SE was still developed by pilocarpine in rats received
the unilateral lesion.11 However, we did not observe signiﬁcant
lesion after the ANT DBS in our study. Nevertheless, micro-
thalamotomy or lesion may occur, and it needs to be further
conﬁrmed. One might also concern the effect of implantation of
ANT stimulating electrode with no electrical stimulation on the
pilocarpine-induced seizures. Our result (Table 1) indicated there
is no signiﬁcant difference in the occurrence rate of EEG seizures
between rats received pilocarpine injections (group-1) and those
received pilocarpine administration with implantation of an ANT
stimulating electrode (group-2).
4.5. Potential translation into humans
Recent DBS would only be applied after epilepsy patients
exhibit the initial epileptogenic insult. According to our current
results, unilateral left ANT DBS has to be employed 1 h before the
S.-B. Jou et al. / Seizure 22 (2013) 221–229 229seizure onset to reduce the incidence of seizure and SE, which
makes the prediction of seizure onset more critical in the DBS
therapy. Our collaborators are currently designing a mathematical
algorithm to analyze EEGs obtained before epilepsy onset and to
predict the onset of epilepsy. Our results indicate that the
mathematical algorithm we created could successfully predict
the occurrence of EEG seizure 1 h before the seizure onset
(personal unpublished data). Combining our predicting algorithm
with high-frequency and low-intensity left ANT DBS may
efﬁciently improve patients with refractory epilepsy in clinic.
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